NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index.
The underlying index is composed of common stocks of 30U. S. pharmaceutical companies.
These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 5.53% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 5.28% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 5.22% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.04% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.03% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.02% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 4.97% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 4.68% |
| BHC | Bausch Health Companies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.90% |
| TARO | Taro Pharmaceutical Industries Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | 3.59% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.39% |
| AVDL | Avadel Pharmaceuticals PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.39% |
| LQDA | Liquidia Technologies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.30% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 3.28% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 3.25% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 3.18% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.95% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.95% |
| HRMY | Harmony Biosciences Holdings | Healthcare | Biotechnology | 2.93% |
| INVA | Innoviva Inc | Healthcare | Biotechnology | 2.92% |